NO20000484L - Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel - Google Patents

Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Info

Publication number
NO20000484L
NO20000484L NO20000484A NO20000484A NO20000484L NO 20000484 L NO20000484 L NO 20000484L NO 20000484 A NO20000484 A NO 20000484A NO 20000484 A NO20000484 A NO 20000484A NO 20000484 L NO20000484 L NO 20000484L
Authority
NO
Norway
Prior art keywords
crystalline
füä1
ethylü
dibenzoäb
hydroxyethoxy
Prior art date
Application number
NO20000484A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000484D0 (no
Inventor
Evan William Snape
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO20000484D0 publication Critical patent/NO20000484D0/no
Publication of NO20000484L publication Critical patent/NO20000484L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
NO20000484A 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel NO20000484L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process
PCT/GB1998/002260 WO1999006381A1 (fr) 1997-08-01 1998-07-28 Derive de dibenzothiazepine cristallin et utilisation de ce dernier en tant qu'agent antipsychotique

Publications (2)

Publication Number Publication Date
NO20000484D0 NO20000484D0 (no) 2000-01-31
NO20000484L true NO20000484L (no) 2000-03-16

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000484A NO20000484L (no) 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Country Status (32)

Country Link
US (2) US6372734B1 (fr)
EP (2) EP1589008B1 (fr)
JP (2) JP2001512109A (fr)
KR (1) KR20010022241A (fr)
CN (1) CN1125058C (fr)
AT (2) ATE444959T1 (fr)
AU (1) AU739255B2 (fr)
BG (1) BG64796B1 (fr)
BR (1) BR9811061A (fr)
CA (1) CA2295792C (fr)
CY (2) CY2200162T2 (fr)
CZ (1) CZ299225B6 (fr)
DE (4) DE69841216D1 (fr)
EE (1) EE04550B1 (fr)
ES (2) ES2296568T3 (fr)
GB (2) GB9716161D0 (fr)
HK (2) HK1029992A1 (fr)
HU (1) HU228620B1 (fr)
ID (1) ID24219A (fr)
IL (1) IL133618A (fr)
MY (1) MY120999A (fr)
NO (1) NO20000484L (fr)
NZ (1) NZ501914A (fr)
PL (1) PL338384A1 (fr)
PT (2) PT1589008E (fr)
RU (1) RU2224754C2 (fr)
SI (2) SI1589008T1 (fr)
SK (1) SK287145B6 (fr)
TR (1) TR200000848T2 (fr)
TW (1) TW533207B (fr)
WO (1) WO1999006381A1 (fr)
ZA (1) ZA986904B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1482945A1 (fr) * 2002-03-20 2004-12-08 Teva Pharmaceutical Industries Ltd. Formes cristallines d'hemifumarate de quetiapine
CA2516646A1 (fr) * 2003-02-22 2004-09-10 Teva Pharmaceutical Industries Ltd. Synthese de la quetiapine et sels acceptables d'un point de vue pharmaceutique de celle-ci
TR200503401T1 (tr) * 2003-03-03 2008-03-21 Hetero Drugs Limited Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
EP1611138A1 (fr) 2003-04-07 2006-01-04 Hetero Drugs Limited Nouvelle forme cristalline de chlorhydrate de dorzolamide
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (fr) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Formes polymorphiques d'hemifumarate de quetiapine
WO2006056772A2 (fr) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Composes pharmaceutiques
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
EP1869007A1 (fr) 2005-04-14 2007-12-26 Teva Pharmaceutical Industries Ltd Processus de preparation de fumarate de quetiapine
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
US8044038B2 (en) * 2005-09-30 2011-10-25 Fermion Oy Crystallization process of quetiapine hemifumarate
WO2007048870A1 (fr) * 2005-10-28 2007-05-03 Fermion Oy Purification d’hemifumarate de quetiapine par cristallisation
US20090215744A1 (en) * 2005-11-18 2009-08-27 Astrazeneca Ab Solid Formulations
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
WO2007062336A2 (fr) * 2005-11-18 2007-05-31 Astrazeneca Ab Formes de sels
JP2009516706A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 結晶形
CN101360503A (zh) * 2005-11-18 2009-02-04 阿斯利康公司 液体制剂
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (fr) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dérivés de dibenzodiazépine
ES2352299T3 (es) 2007-02-14 2011-02-17 Laboratorios Lesvi, S.L. Composiciones farmacéuticas que contienen fumarato de quetiapina.
US20080241949A1 (en) * 2007-03-29 2008-10-02 Vinod Kumar Kansal Process for preparing quetiapine fumarate
US8101597B2 (en) * 2007-05-07 2012-01-24 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
AU2008333226B2 (en) * 2007-12-05 2013-02-07 Janssen Pharmaceutica Nv Dibenzoazepine and dibenzooxazepine TRPA1 agonists
EA018638B1 (ru) 2008-08-01 2013-09-30 Крка, Товарна Здравил, Д. Д., Ново Место Композиция кветиапина
US20100069356A1 (en) * 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
JP2012519683A (ja) 2009-03-04 2012-08-30 ランバクシー ラボラトリーズ リミテッド フマル酸クエチアピンの調製方法
EP2742152B1 (fr) 2011-08-12 2017-04-12 Qiagen GmbH Procédé d'isolation d'acides nucléiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
ES2296568T3 (es) 2011-05-06
HK1081962A1 (en) 2006-05-26
ATE496037T1 (de) 2011-02-15
DE69842104D1 (de) 2011-03-03
DE98936529T1 (de) 2008-11-20
ES2296575T3 (es) 2010-02-05
HU228620B1 (en) 2013-04-29
US6372734B1 (en) 2002-04-16
DE05011169T1 (de) 2008-11-06
NZ501914A (en) 2001-09-28
ES2296575T1 (es) 2008-05-01
CZ2000341A3 (cs) 2000-05-17
EP1589008A1 (fr) 2005-10-26
ATE444959T1 (de) 2009-10-15
EP1000043A1 (fr) 2000-05-17
AU739255B2 (en) 2001-10-04
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
EE04550B1 (et) 2005-10-17
BG104176A (en) 2000-08-31
WO1999006381A1 (fr) 1999-02-11
CN1265101A (zh) 2000-08-30
CA2295792A1 (fr) 1999-02-11
ZA986904B (en) 1999-02-01
HUP0002663A3 (en) 2001-10-29
CN1125058C (zh) 2003-10-22
GB9814882D0 (en) 1998-09-09
AU8549898A (en) 1999-02-22
ES2296568T1 (es) 2008-05-01
ID24219A (id) 2000-07-13
EE200000062A (et) 2000-10-16
TR200000848T2 (tr) 2000-08-21
PL338384A1 (en) 2000-10-23
SI1589008T1 (sl) 2011-04-29
PT1589008E (pt) 2011-03-23
BG64796B1 (bg) 2006-04-28
PT1000043E (pt) 2009-11-30
RU2224754C2 (ru) 2004-02-27
EP1589008B1 (fr) 2011-01-19
SK1302000A3 (en) 2000-06-12
CZ299225B6 (cs) 2008-05-21
NO20000484D0 (no) 2000-01-31
CY2200162T2 (el) 2010-07-28
BR9811061A (pt) 2000-09-19
EP1000043B1 (fr) 2009-10-07
JP2009102345A (ja) 2009-05-14
KR20010022241A (ko) 2001-03-15
JP2001512109A (ja) 2001-08-21
HK1029992A1 (en) 2001-04-20
GB9716161D0 (en) 1997-10-08
CY2200161T2 (el) 2010-07-28
HUP0002663A2 (hu) 2001-09-28
TW533207B (en) 2003-05-21
SI1000043T1 (sl) 2010-01-29
CA2295792C (fr) 2007-04-17
US20020147186A1 (en) 2002-10-10
DE69841216D1 (de) 2009-11-19
MY120999A (en) 2005-12-30
SK287145B6 (sk) 2010-01-07

Similar Documents

Publication Publication Date Title
NO20000484D0 (no) Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
AU2002213515A1 (en) An apparatus convertible to a chair or treatment table
ES2182079T3 (es) Composiciones farmaceuticas de liberacion sostenida que contienen un derivado de dibenzotiazepina.
NO303641B1 (no) Optisk aktive benzotiepinderivater, mellomprodukter for deres fremstilling og deres anvendelse
FI962639A (fi) Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina
AU3696197A (en) Process for the recovery of crystalline beta-carotene from natural source
NO980923D0 (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
AU4009497A (en) Substituted pyrazolyl-pyrazole derivatives, process for their preparation nd their use as agents with a herbicidal effect
DK1075471T3 (da) Idolylderivater som serotonerge midler
NO942472D0 (no) Okulært hypotensivt middel
NO993812D0 (no) (4-piperidinyl)-1H-2benzopyranderivater som er anvendbare som antipsykotiske midler
ES2091285T3 (es) 2-hidroxi-1,2,3-propanotricarboxilato de 3-((5-metil-2-furanil)-metil)-n-(4-piperidinil)-3h-imidazo-(4,5-b)-piridin-2-amina.
FI980947A0 (fi) Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi
DK0789658T3 (da) Styreindretning til at opnå optimal anvendelse af den energi, der frembringes af et fartøjs hovedenergikilde
AU7641291A (en) Composition for disinfecting water by the electrochlorination process and use of this composition
AU7379794A (en) Aza-5,5-fused heterocyclic acids as leukotriene antagonists
KR940022660U (ko) 유기물 발효기용 탈취장치
IT9022077A0 (it) Procedimento per il recupero dei residui stirenici solforati.
IT236181Y1 (it) Punta perfezionata per chirurgia oculistica,in particolare per larimozione della cataratta
SE9602476D0 (sv) Process for the preparation of organic salts of N'N -diacetylcystine
SE9602418D0 (sv) Process for the preparation of organic salts of N'N-diacetylcystine
RU97117486A (ru) Средство для уничтожения пресноводных моллюсков